ciprofloxacin has been researched along with Pulmonary Consumption in 47 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report three patients who experienced hepatotoxic reactions in association with acetaminophen ingestion while undergoing treatment for active tuberculosis with isoniazid, rifampin, and other agents." | 7.69 | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. ( Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE, 1994) |
| " Adverse events were recorded in only two patients and involved a slight elevation in liver function tests and eosinophilia." | 5.30 | The efficacy, safety and pharmacokinetics of intravenous ciprofloxacin in patients with lower respiratory tract infections. ( Hiraga, Y; Ohmichi, M, 1999) |
| "We report three patients who experienced hepatotoxic reactions in association with acetaminophen ingestion while undergoing treatment for active tuberculosis with isoniazid, rifampin, and other agents." | 3.69 | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. ( Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE, 1994) |
| "Twenty-five patients who had extensive pulmonary tuberculosis and hepatitis induced by antituberculosis drugs were treated with ciprofloxacin together with other relatively non-hepatotoxic drugs, either during the interim phase awaiting recovery of liver function in some, or as definitive therapy as required by the compromised hepatic status of others." | 2.68 | Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction. ( Chan, CY; Chau, CH; Cheng, AF; Cheung, SW; Lee, J; Wong, CF; Wong, PC; Yew, WW, 1995) |
| " We aim to compare the culture conversion between new-generation (levofloxacin and moxifloxacin) and old-generation (ciprofloxacin and ofloxacin) fluoroquinolones, develop pharmacokinetic models, and calculate target attainment for levofloxacin and moxifloxacin." | 1.51 | Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. ( Ahmed, S; Al-Shaer, MH; Alghamdi, WA; Alkabab, Y; Alsultan, A; An, G; Banu, S; Barbakadze, K; Cegielski, JP; Heysell, SK; Houpt, E; Kempker, RR; Kipiani, M; Mikiashvili, L; Peloquin, CA, 2019) |
| " Lead optimization resulted in the identification of potent compounds with improved oral bioavailability and reduced cardiac ion channel liability." | 1.40 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. ( Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J, 2014) |
| " The interactions between antibiotic treatment and cyclosporine therapy should be observed closely in organ transplant recipients, requiring frequent level determinations and dosing changes." | 1.33 | Successful management of two heart transplant recipients with mycobacterial pulmonary infections. ( Barten, M; Bittner, HB; Bossert, T; Gummert, JF; Mohr, FW; Rahmel, A; Richter, M, 2005) |
| "We report a chronic case of pulmonary tuberculosis in a Malagasy citizen from Antsohihy (West of Madagascar), who was infected with a multi-drug resistant Mycobacterium bovis strain." | 1.32 | [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. ( Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V, 2003) |
| " Adverse events were recorded in only two patients and involved a slight elevation in liver function tests and eosinophilia." | 1.30 | The efficacy, safety and pharmacokinetics of intravenous ciprofloxacin in patients with lower respiratory tract infections. ( Hiraga, Y; Ohmichi, M, 1999) |
| "Ciprofloxacin was used primarily to treat Mycobacterium avium complex (MAC) infection, dosed to achieve 2-hour post-dose serum concentrations of 4-6 micrograms/ml." | 1.29 | Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections. ( Berning, SE; Iseman, MD; Madsen, L; Peloquin, CA, 1995) |
| " Serial plasma samples taken under controlled conditions suggested that a decreased rate of absorption was responsible for low one-hour concentrations in one of the subjects." | 1.28 | Ciprofloxacin in patients with mycobacterial infections: experience in 15 patients. ( Kahana, LM; Spino, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.13) | 18.7374 |
| 1990's | 23 (48.94) | 18.2507 |
| 2000's | 16 (34.04) | 29.6817 |
| 2010's | 7 (14.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lenaerts, AJ | 1 |
| Bitting, C | 1 |
| Woolhiser, L | 1 |
| Gruppo, V | 1 |
| Marietta, KS | 1 |
| Johnson, CM | 1 |
| Orme, IM | 1 |
| Hameed P, S | 1 |
| Patil, V | 1 |
| Solapure, S | 1 |
| Sharma, U | 1 |
| Madhavapeddi, P | 1 |
| Raichurkar, A | 1 |
| Chinnapattu, M | 1 |
| Manjrekar, P | 1 |
| Shanbhag, G | 1 |
| Puttur, J | 1 |
| Shinde, V | 1 |
| Menasinakai, S | 1 |
| Rudrapatana, S | 1 |
| Achar, V | 1 |
| Awasthy, D | 1 |
| Nandishaiah, R | 1 |
| Humnabadkar, V | 1 |
| Ghosh, A | 1 |
| Narayan, C | 1 |
| Ramya, VK | 1 |
| Kaur, P | 1 |
| Sharma, S | 1 |
| Werngren, J | 1 |
| Hoffner, S | 1 |
| Panduga, V | 1 |
| Kumar, CN | 1 |
| Reddy, J | 1 |
| Kumar K N, M | 1 |
| Ganguly, S | 1 |
| Bharath, S | 1 |
| Bheemarao, U | 1 |
| Mukherjee, K | 1 |
| Arora, U | 1 |
| Gaonkar, S | 1 |
| Coulson, M | 1 |
| Waterson, D | 1 |
| Sambandamurthy, VK | 1 |
| de Sousa, SM | 1 |
| Al-Shaer, MH | 1 |
| Alghamdi, WA | 1 |
| Alsultan, A | 1 |
| An, G | 1 |
| Ahmed, S | 1 |
| Alkabab, Y | 1 |
| Banu, S | 1 |
| Barbakadze, K | 1 |
| Houpt, E | 1 |
| Kipiani, M | 1 |
| Mikiashvili, L | 1 |
| Cegielski, JP | 1 |
| Kempker, RR | 1 |
| Heysell, SK | 1 |
| Peloquin, CA | 2 |
| Ziganshina, LE | 3 |
| Titarenko, AF | 1 |
| Davies, GR | 1 |
| Wang, JY | 1 |
| Lee, CH | 1 |
| Yu, MC | 1 |
| Lee, MC | 1 |
| Lee, LN | 1 |
| Wang, JT | 1 |
| Bhardwaj, A | 1 |
| Grobler, A | 1 |
| Rath, G | 1 |
| Goyal, AK | 1 |
| Jain, AK | 1 |
| Mehta, A | 1 |
| Li, W | 1 |
| Obregón-Henao, A | 1 |
| Wallach, JB | 1 |
| North, EJ | 1 |
| Lee, RE | 1 |
| Gonzalez-Juarrero, M | 1 |
| Schnappinger, D | 1 |
| Jackson, M | 1 |
| Disratthakit, A | 1 |
| Prammananan, T | 1 |
| Tribuddharat, C | 1 |
| Thaipisuttikul, I | 1 |
| Doi, N | 1 |
| Leechawengwongs, M | 1 |
| Chaiprasert, A | 1 |
| Murray, MP | 1 |
| Laurenson, IF | 1 |
| Hill, AT | 1 |
| Gillespie, SH | 5 |
| Charalambous, BM | 2 |
| Yang, CK | 1 |
| Lin, HC | 1 |
| Lee, KY | 1 |
| Lin, SM | 1 |
| Yu, CT | 1 |
| Kuo, HP | 1 |
| Marra, F | 1 |
| Cox, VC | 1 |
| FitzGerald, JM | 1 |
| Moadebi, S | 1 |
| Elwood, RK | 1 |
| Suárez-Méndez, R | 1 |
| García-García, I | 1 |
| Fernández-Olivera, N | 1 |
| Valdés-Quintana, M | 1 |
| Milanés-Virelles, MT | 1 |
| Carbonell, D | 1 |
| Machado-Molina, D | 1 |
| Valenzuela-Silva, CM | 1 |
| López-Saura, PA | 1 |
| Ramarokoto, H | 1 |
| Andrianasolo, D | 1 |
| Rasolonavalona, T | 1 |
| Ramaroson, F | 1 |
| Razafitsiarovana, I | 1 |
| Vincent, V | 1 |
| Ratsimba, L | 1 |
| Rasolofo Razanamparany, V | 1 |
| Dam, T | 1 |
| Isa, M | 1 |
| Bose, M | 1 |
| Vizel, AA | 1 |
| Squire, SB | 2 |
| Bossert, T | 1 |
| Bittner, HB | 1 |
| Richter, M | 1 |
| Rahmel, A | 1 |
| Barten, M | 1 |
| Gummert, JF | 1 |
| Mohr, FW | 1 |
| Francois Venter, WD | 1 |
| Panz, VR | 1 |
| Feldman, C | 1 |
| Joffe, BI | 1 |
| Krüüner, A | 1 |
| Yates, MD | 1 |
| Drobniewski, FA | 1 |
| Jenkins, PA | 1 |
| Campbell, IA | 1 |
| Banks, J | 1 |
| Gelder, CM | 1 |
| Prescott, RJ | 1 |
| Smith, AP | 1 |
| Nolan, CM | 1 |
| Sandblom, RE | 1 |
| Thummel, KE | 1 |
| Slattery, JT | 1 |
| Nelson, SD | 1 |
| Yew, WW | 3 |
| Chau, CH | 3 |
| Wong, PC | 2 |
| Lee, J | 1 |
| Wong, CF | 1 |
| Cheung, SW | 1 |
| Chan, CY | 1 |
| Cheng, AF | 1 |
| Stevens, JP | 1 |
| Daniel, TM | 1 |
| Sirgel, FA | 2 |
| Venter, A | 1 |
| Heilmann, HD | 1 |
| Berning, SE | 1 |
| Madsen, L | 1 |
| Iseman, MD | 1 |
| Choi, HY | 1 |
| Mitchison, DA | 2 |
| Tasaka, S | 1 |
| Urano, T | 1 |
| Mori, M | 1 |
| Yamaguchi, K | 1 |
| Kanazawa, M | 1 |
| O'Brien, RJ | 1 |
| Nunn, PP | 1 |
| Kennedy, N | 3 |
| Fox, R | 3 |
| Uiso, L | 1 |
| Ngowi, FI | 3 |
| Kisyombe, GM | 2 |
| Saruni, AO | 2 |
| Uiso, LO | 2 |
| Ramsay, AR | 2 |
| Mineshita, M | 1 |
| Miyazawa, T | 1 |
| Doi, M | 1 |
| Suei, S | 1 |
| Matsuura, M | 1 |
| Senoo, T | 1 |
| Yamakido, M | 1 |
| Mohanty, KC | 1 |
| Dhamgaye, TM | 1 |
| Berger, L | 1 |
| Curram, J | 1 |
| Gutmann, J | 1 |
| Sam, N | 1 |
| Tillotson, G | 1 |
| Yates, M | 1 |
| Fisher, M | 1 |
| Tomlinson, DR | 1 |
| Coker, RJ | 1 |
| Botha, FJ | 1 |
| Parkin, DP | 1 |
| Van de Wal, BW | 1 |
| Schall, R | 1 |
| Donald, PR | 1 |
| Lalonde, RG | 1 |
| Barkun, J | 1 |
| Gach, O | 1 |
| Corhay, JL | 1 |
| Lousberg, L | 1 |
| Bartsch, P | 1 |
| Ohmichi, M | 1 |
| Hiraga, Y | 1 |
| Grimaldo, ER | 1 |
| Tupasi, TE | 1 |
| Rivera, AB | 1 |
| Quelapio, MI | 1 |
| Cardaño, RC | 1 |
| Derilo, JO | 1 |
| Belen, VA | 1 |
| Gosling, RD | 1 |
| Kahana, LM | 1 |
| Spino, M | 1 |
| Bhatti, N | 1 |
| Chronos, N | 1 |
| White, JP | 1 |
| Larson, E | 1 |
| Burns, DN | 1 |
| Rohatgi, PK | 1 |
| Rosenthal, R | 1 |
| Seiler, M | 1 |
| Gordin, FM | 1 |
| Chen, CH | 1 |
| Shih, JF | 1 |
| Lindholm-Levy, PJ | 1 |
| Heifets, LB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi[NCT01298336] | Phase 3 | 92 participants (Actual) | Interventional | 2011-03-02 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ciprofloxacin and Pulmonary Consumption
| Article | Year |
|---|---|
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Topics: Antitubercular Agents; Ciprofloxacin; Drug Substitution; Fluoroquinolones; Humans; Levofloxacin; Ofl | 2013 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized | 2005 |
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized | 2008 |
Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan.
Topics: Antitubercular Agents; Ciprofloxacin; Culture Media; Dose-Response Relationship, Drug; Drug Resistan | 1989 |
12 trials available for ciprofloxacin and Pulmonary Consumption
| Article | Year |
|---|---|
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Ba | 2008 |
A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens.
Topics: Antitubercular Agents; Cell Survival; Ciprofloxacin; Drug Administration Schedule; Humans; Isoniazid | 2003 |
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bact | 2004 |
Adrenocortical function in hospitalised patients with active pulmonary tuberculosis receiving a rifampicin-based regimen -- a pilot study.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aldosterone; Antibiotics, Antitubercular; Biomar | 2006 |
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin | 2008 |
Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cipro | 1995 |
Ciprofloxacin is not a component of first-line TB.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Tuberculosis, Pulmonary | 1994 |
Safety profile of ciprofloxacin during long-term therapy for pulmonary tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Ciprofloxacin; Drug Therapy, Combination; Enzyme-Linked Im | 1993 |
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1 | 1993 |
Controlled trial of ciprofloxacin in short-term chemotherapy for pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Drug | 1993 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciproflo | 1996 |
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Colony Count, Microbial; Drug Th | 1997 |
31 other studies available for ciprofloxacin and Pulmonary Consumption
| Article | Year |
|---|---|
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; | 2008 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological | 2014 |
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ciprofloxacin; Dose-Response Rela | 2019 |
Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; | 2015 |
Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis.
Topics: Administration, Inhalation; Aniline Compounds; Animals; Antitubercular Agents; Cells, Cultured; Cipr | 2016 |
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Topics: Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; Biological Transport; Ciprofloxa | 2016 |
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extens | 2016 |
The effects of ciprofloxacin on chest radiographic regression in patients with drug intolerance or resistant tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Resistance, Bacterial; Drug Tolerance; Female; Humans; Male; Middle | 2004 |
Successful treatment of multidrug-resistant tuberculosis following drug-induced hepatic necrosis requiring liver transplant.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ciprofl | 2004 |
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; | 2003 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India | 2005 |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Heart Failure; Heart Tr | 2005 |
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroqui | 2006 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Fema | 1994 |
Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide. A decision analysis.
Topics: Adult; Ciprofloxacin; Decision Support Techniques; Decision Trees; Health Personnel; HIV Seronegativ | 1995 |
Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobac | 1995 |
Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Age | 1995 |
Ciprofloxacin-induced renal dysfunction in patients with mycobacterial lung infections.
Topics: Acute Kidney Injury; Aged; Ciprofloxacin; Female; Humans; Male; Mycobacterium Infections, Nontubercu | 1995 |
Early bactericidal activity and sterilizing activity of ciprofloxacin in pulmonary tuberculosis.
Topics: Ciprofloxacin; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Tuberculosis, Pulmonar | 1995 |
[A case of Mycobacterium fortuitum pulmonary disease in a healthy young woman successfully treated with ciprofloxacin and doxycycline].
Topics: Adult; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; Mycobacterium Infectio | 1995 |
[Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Mi | 1993 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitu | 1996 |
Prolonged ciprofloxacin therapy fails to prevent reactivation tuberculosis.
Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Humans; Male; Mycobacterium tuber | 1998 |
Fluoroquinolones and tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tubercul | 1998 |
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breas | 1999 |
The efficacy, safety and pharmacokinetics of intravenous ciprofloxacin in patients with lower respiratory tract infections.
Topics: Adult; Aged; Anti-Infective Agents; Bronchiectasis; Bronchiolitis; Ciprofloxacin; Female; Humans; In | 1999 |
Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Resistance, Mu | 2001 |
A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clinical Trials as Topic; Colony Count, | 2002 |
Ciprofloxacin in patients with mycobacterial infections: experience in 15 patients.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Ciprofloxacin; Drug Therapy, Combinati | 1991 |
A case of resistant tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; | 1990 |
Disseminated Mycobacterium fortuitum successfully treated with combination therapy including ciprofloxacin.
Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Drainage; Humans; Male; Minocycline; Mycobacterium I | 1990 |